Диссертация (1145009), страница 70
Текст из файла (страница 70)
Clin. N. Am. – 2005. –Vol. 89, N 2. – P. 313-44.424. Martines Torres A. Helicobacter pylori: a new cardiovascular risk factor? / A.Martines Torres, M. Martines Gaensly // Rev. Esp. Cardiol. – 2002. – Vol. 55, N 6.– P. 652-56.425. Maruyama Y. Inflammation and oxidative stress in ESRD the role ofmyeloperoxidasse / Y. Maruyama, B. Lindholm, P. Stenvinkel et all // J. Nephrol. –2004. – Vol. 17, N 8. – P.
72-76.426. Matsuura E. Preventing autoimmune and infection triggered atherosclerosis for anenduring healthful lifestyle / E. Matsuura, K. Kobayashi, L.R. Lopez // Autoimmunity Reviews. – 2007. – Vol. 6, N 7. – P. 233-37.397427. Mattapallil J.J. A predominant Th1-type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques / J.J. Mattapallil, S.Dandekar, D.R. Canfield, J.V. Solnick // Gastroenterology.
– 2000. – Vol. 118, N 2.– P. 307-15.428. Mayr M. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study / M. Mayr, S. Kiechl,M.A. Mendall, J. Willeit et all // Stroke. – 2003. – Vol. 34, N 3. – P. 610-15.429. Mazora R.
Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients / R. Mazora, R.Shurtz-Swirskia, R. Farahb et all // Atherosclerosis. – 2008. – Vol. 197, N 2. – P.937-43.430. McBee M.E. Modulation of acute diarrheal illness by persistent bacterial infection/ M.E. McBee, P.Z. Zheng, A.B. Rogers, J.G. Fox, D.B. Schauer // Infect.
Immun. –2008. – N 76. – P. 4851-58.431. Mendall M.A. Relation of Helicobacter pylori infection and coronary heart disease/ M.A. Mendall, P. Goggin, J. Levy et all // Br. Heart J. – 1994. – N 71. – P. 437-39.432. Mendall M.A. Relation of serum cytokine concentrations to cardiovascular riskfactors and coronary heart disease / M.A. Mendall, P. Patel, M. Asante et all //Heart. – 1997. – Vol.
78, N 3. – P. 273-77.433. Mendall M.A. C-reactive protein and its relation to cardiovascular risk factors: apopulation based cross sectional study / M.A. Mendall, P. Patel, L. Ballam et all //Br. Med. J. – 1996. – N 312. – P. 1061-65.434.
Mestecky J. The mucosal immune system / J. Mestecky, R.S. Blumberg, H.Kiyono, J.R. McGhee. In W.E. Paul (ed.), Fundamental immunology, 5th ed. –Lippincott Williams & Wilkins, Philadelphia, PA., 2003. – P. 965-1020.435. Migneco А. Eradication of Helicobacter pylori infection improves blood pressurevalues in patients affected by hypertension / А. Migneco, V. Ojetti, L. Specchia etall // Helicobacter. – 2003. – N 8.
– P. 585-89.398436. Milioti N. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis / N. Milioti, A. Bermudez-Fajardo, M.L. Penichet // Clin. Dev. Immunol. –2008. – N 723. – P. 35-39.437. Miller Y.I. Oxidized low density lipoprotein and innate immune receptor / Y.I.Miller, M.K. Chang, C.J. Binder, P.X.
Shaw, J.L. Witztum // Curr. Opin. Lipidol. –2003. – N 14. – P. 437-45.438. Misia-Stek K. Hyperlipidemias and serum cytokines in patients with coronary artery disease / K. Misia-Stek, B. Zahorska-Markiewicz, T. Mandeski et all // ActaCardiol. – 2003. – Vol. 58, N 1. – P. 9-15.439.
Moran A.P. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori / A.P. Moran // Carbohydr. Res. –2008. – N 343. – P. 1952-65.440. Morrow D.A. Future of biomarkers in acute coronary syndromes: moving toward amultimarker strategy / D.A. Morrow, E. Braunwald // Circulation. – 2003. – Vol.108, N 3. – P. 250-52.441. Mosmann T.R. Th1 and Th2 cells: different patterns of lymphokine secretion leadto different functional properties / T.R.
Mosmann, R.L. Coffman // Ann. Rev.Immunol. – 1989. – N 7. – P. 145-73.442. Muhlestein J.B. Infectious serology and atherosclerosis: how burdensome is therisk? / J.B. Muhlestein, J.L. Anderson // Circulation. – 2003. – Vol. 107. N 2. – P.220-22.443. Murakami T. Modification of macrophage function and effects on atherosclerosis /T. Murakami, N. Yamada // Curr. Opin. Lipidol. – 1996. – N 7. – P. 320-23.444.
Murray L.J. Helicobacter pylori infection: relation with cardiovascular risk factors,ischemic heart disease, and social class / L.J. Murray, K.B. Bamford, D.P. O.Reillyet all // Br. Heart J. – 1995. – N 74. – P. 497-501.445. Muzio M. The human toll signaling pathway: divergence of NF-B and JNK/SAPKactivation upstream of tumor necrosis factor receptor-associated factor 6 / M. Muzio,399G.
Natoli, S. Saccani, M. Levrero, A. Mantovani // J. Exp. Med. – 1998. – N 187. –P. 2097-101.446. Nabwera H.M. Epidemiology of Helicobacter pylori: transmission, translocationand extragastric reservoirs / H.M. Nabwera, R.P. Logan // J. Physiol. Pharmacol. –1999. – N 50. – P. 711-22.447. Nagai S. Role of Peyer’s patches in the induction of Helicobacter pylori-inducedgastritis / S. Nagai, H. Mimuro, T. Yamada, Y.
Baba et all // PNAS. – 2007. – Vol.104, N 21. – P. 8971-76.448. Nakae S. Phenotypic differences between Th1 and Th17 cells and negativeregulation of Th1 cell differentiation by IL-17 / S. Nakae, Y. Iwakura, H. Suto, S.J.Galli // J. Leukoc. Biol. – 2007. – N 81.
– P. 1258-68.449. Neri Serneri G.G. Transient intermittent lymphocyte activation is responsible forthe instability of angina / G.G. Neri Serneri, R. Abbate, A.M. Gori et all // Circulation. – 1992. – N 86. – P. 790-97.450. Neutra M.R. Role of M cells in transepithelial transport of antigens and pathogensto the mucosal immune system / M.R. Neutra // Am. J.
Physiol. – 1998. – N 274. –P. G785-G791.451. Niccoli G. Coronary atherosclerotic burden in patients with infection by CagApositive strains of Helicobacter pylori / G. Niccoli, F. Franceschi, N. Cosentino etall // Coron. Artery Dis. – 2010. – N 21. – P. 217-21.452. Nicholson A.C. Expression of CD36 in macrophages and atherosclerosis. The roleof lipid regulation of PPARy signaling / A.C. Nicholson // Trends Cardiovasc. Med.– 2004. – N 14. – P. 8-12.453. Niemela S. Could Helicobacter pylori infection increase the risk of coronary heartdisease by modifying serum lipid concentrations? / S. Niemela, T.
Karttunen, T.Korhonen et all // Heart. – 1996. – Vol. 75, N 6. – P. 573-75.454. Nikkari S.T. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis / S.T. Nikkari, K.D. O'Brien, M. Ferguson et all // Circulation. – 1995. – N92. – P. 1393-98.400455. Nilius M. IL-8 release by Helicobacter pylori is potentiated by monocytes in vitro /M. Nilius, U. Schuppert, K. Sierla, P. Malfertheiner // (Abstracts.). – DDW, 1996.456.
Nilsson C. Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases / C. Nilsson, A. Skoglund,A.P. Moran, H. Annuk et all // PLoS. ONE. – 2008. – N 3. – P. 3811-24.457. Nishikawa J.
Seroprevalence of immunoglobulin G antibodies against Helicobacterpylori among endoscopy personnel in Japan / J. Nishikawa, H. Kawai, A. Takahashiet all // Gastrointestinal Endoscopi. – 1998. – Vol. 48, N 3. – P. 237-43.458. Noach L.A. Mucosal tumor necrosis factor-alpha, Interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection / L.A. Noach, N.B.Bosma, J.
Jansen et all // Scand. J. Gastroenterol. – 1994. – Vol. 29, N 5. – P. 42529.459. Ojetti V. The role of H. pylori infection in diabetes / V. Ojetti, A. Migneco, N.G.Silveri et all // Curr. Diabetes Rev. – 2005. – Vol. 1, N 3. – P. 343-47.460. Ojetti V. Helicobacter pylori infection and diabetes / V. Ojetti, R. Pellicano, S.Fagoonee et all // Minerva Med. – 2010. – Vol. 101 N 2. – P. 115-19.461. Oleastro M. Evaluation of the clinical significance of homB, a novel candidatemarker of Helicobacter pylori strains associated with peptic ulcer disease / M.Oleastro, R.
Cordeiro, J. Ferrand et all // J. Infect. Dis. – 2008. – N 198. – P. 137987.462. Oliveira G.H. Novel serologic markers of cardiovascular risk / G.H. Oliveira //Curr. Atheroscler. Rep. – 2005. – N 7. – P. 148-54.463. Opal S.M. Anti-inflammatory cytokines / S.M. Opal, V.A. DePalo // Chest.
–2000. – Vol. 117, N 4. – P. 1162-72.464. Oshima T. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects / T. Oshima, R. Ozono, Y.Yano, H. Teragawa et all // J. Am. Coll. Cardiol. – 2005. – Vol. 45, N 8. – P. 121922.401465. Osterud B. Role monocytes in atherogenesis / B. Osterud, E. Bjorklid // Physiol.Rew. – 2003. – N 83. – P. 341-90.466. Park H. A distinct lineage of CD4 T cells regulates tissue inflammation byproducing interleukin 17 / H. Park, Z.X. Li, X.O.
Yang, S.H. Chang et all // Nat.Immunol. – 2005. – N 6. – P. 1133-41.467. Park M.J. Association between Helicobacter pylori seropositivity and the coronaryartery calcium score in a screening population / M.J. Park, S.H. Choi, D. Kim et all// Gut Liver. – 2011. – Vol. 5, N 3. – P. 321-27.468. Pasceri V. Association of virulent Helicobacter pylori strains with ischemic heartdisease / V. Pasceri, G.
Cammarota, G. Patti et all // Circulation. – 1998. – Vol. 97,N 17. – P. 1675-79.469. Pasceri V. Virulent strains of Helicobacter pylori and vascular diseases: A metaanalysis / V. Pasceri, G. Patti, G. Cammarota et all // American Heart Journal. –2006. – N 6. – P. 1215-22.470. Patel P. Association of Helicobacter pylori and Chlamydia pneumoniae infectionswith coronary heart disease and cardiovascular risk factors / P. Patel, M.A. Menall etall // Br.
Med. J. – 1995. – N 311. – P. 711-14.471. Pearce H.R. Effects of Helicobacter pylori on endothelial cell proliferation andchemotaxis / H.R. Pearce, N. Kalia, K.D. Bardhan et all // Digestion. – 2004. – N 69.– P. 201-10.472. Peek R.M. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome / R.M. Peek // Proc.Assoc. Am. Physicians. – 1998. – Vol. 110, N 6. – P.
531-44.473. Peek R.M.Jr. Heightened inflammatory response and cytokine expression in vivoto cagA+ Helicobacter pylori strains / R.M.Jr. Peek, G.G. Miller, K.T. Tham et all //Lab. Invest. – 1995. – Vol. 73, N 6. – P. 760-70.474. Peiser L. Scavenger receptors in innate immunity / L. Peiser, S. Mukhopadhyay, S.Gordon // Curr. Opin. Immunol. – 2002. – N 14. – P. 123-28.402475. Pellicano R.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
